BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 33828235)

  • 1. Precision medicine for mood disorders: objective assessment, risk prediction, pharmacogenomics, and repurposed drugs.
    Le-Niculescu H; Roseberry K; Gill SS; Levey DF; Phalen PL; Mullen J; Williams A; Bhairo S; Voegtline T; Davis H; Shekhar A; Kurian SM; Niculescu AB
    Mol Psychiatry; 2021 Jul; 26(7):2776-2804. PubMed ID: 33828235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Precision medicine for suicidality: from universality to subtypes and personalization.
    Niculescu AB; Le-Niculescu H; Levey DF; Phalen PL; Dainton HL; Roseberry K; Niculescu EM; Niezer JO; Williams A; Graham DL; Jones TJ; Venugopal V; Ballew A; Yard M; Gelbart T; Kurian SM; Shekhar A; Schork NJ; Sandusky GE; Salomon DR
    Mol Psychiatry; 2017 Sep; 22(9):1250-1273. PubMed ID: 28809398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Towards understanding and predicting suicidality in women: biomarkers and clinical risk assessment.
    Levey DF; Niculescu EM; Le-Niculescu H; Dainton HL; Phalen PL; Ladd TB; Weber H; Belanger E; Graham DL; Khan FN; Vanipenta NP; Stage EC; Ballew A; Yard M; Gelbart T; Shekhar A; Schork NJ; Kurian SM; Sandusky GE; Salomon DR; Niculescu AB
    Mol Psychiatry; 2016 Jun; 21(6):768-85. PubMed ID: 27046645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding and predicting suicidality using a combined genomic and clinical risk assessment approach.
    Niculescu AB; Levey DF; Phalen PL; Le-Niculescu H; Dainton HD; Jain N; Belanger E; James A; George S; Weber H; Graham DL; Schweitzer R; Ladd TB; Learman R; Niculescu EM; Vanipenta NP; Khan FN; Mullen J; Shankar G; Cook S; Humbert C; Ballew A; Yard M; Gelbart T; Shekhar A; Schork NJ; Kurian SM; Sandusky GE; Salomon DR
    Mol Psychiatry; 2015 Nov; 20(11):1266-85. PubMed ID: 26283638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Towards precision medicine for anxiety disorders: objective assessment, risk prediction, pharmacogenomics, and repurposed drugs.
    Roseberry K; Le-Niculescu H; Levey DF; Bhagar R; Soe K; Rogers J; Palkowitz S; Pina N; Anastasiadis WA; Gill SS; Kurian SM; Shekhar A; Niculescu AB
    Mol Psychiatry; 2023 Jul; 28(7):2894-2912. PubMed ID: 36878964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery and validation of blood biomarkers for suicidality.
    Le-Niculescu H; Levey DF; Ayalew M; Palmer L; Gavrin LM; Jain N; Winiger E; Bhosrekar S; Shankar G; Radel M; Bellanger E; Duckworth H; Olesek K; Vergo J; Schweitzer R; Yard M; Ballew A; Shekhar A; Sandusky GE; Schork NJ; Kurian SM; Salomon DR; Niculescu AB
    Mol Psychiatry; 2013 Dec; 18(12):1249-64. PubMed ID: 23958961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood biomarkers for memory: toward early detection of risk for Alzheimer disease, pharmacogenomics, and repurposed drugs.
    Niculescu AB; Le-Niculescu H; Roseberry K; Wang S; Hart J; Kaur A; Robertson H; Jones T; Strasburger A; Williams A; Kurian SM; Lamb B; Shekhar A; Lahiri DK; Saykin AJ
    Mol Psychiatry; 2020 Aug; 25(8):1651-1672. PubMed ID: 31792364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Towards precision medicine for stress disorders: diagnostic biomarkers and targeted drugs.
    Le-Niculescu H; Roseberry K; Levey DF; Rogers J; Kosary K; Prabha S; Jones T; Judd S; McCormick MA; Wessel AR; Williams A; Phalen PL; Mamdani F; Sequeira A; Kurian SM; Niculescu AB
    Mol Psychiatry; 2020 May; 25(5):918-938. PubMed ID: 30862937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Letter to the Editor: CONVERGENCES AND DIVERGENCES IN THE ICD-11 VS. DSM-5 CLASSIFICATION OF MOOD DISORDERS.
    Cerbo AD
    Turk Psikiyatri Derg; 2021; 32(4):293-295. PubMed ID: 34964106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mood, stress and longevity: convergence on ANK3.
    Rangaraju S; Levey DF; Nho K; Jain N; Andrews KD; Le-Niculescu H; Salomon DR; Saykin AJ; Petrascheck M; Niculescu AB
    Mol Psychiatry; 2016 Aug; 21(8):1037-49. PubMed ID: 27217151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Precision medicine for psychotic disorders: objective assessment, risk prediction, and pharmacogenomics.
    Hill MD; Gill SS; Le-Niculescu H; MacKie O; Bhagar R; Roseberry K; Murray OK; Dainton HD; Wolf SK; Shekhar A; Kurian SM; Niculescu AB
    Mol Psychiatry; 2024 May; 29(5):1528-1549. PubMed ID: 38326562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suicidality and its associated factors among mood disorder patients in emergency department in China: a comparative study using propensity score matching approach.
    Xie XM; Wang YF; Han T; Liu Y; Li J; Zhu H; Jiang T; Ji X; Cai H
    Transl Psychiatry; 2023 Dec; 13(1):372. PubMed ID: 38040690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ECNP consensus meeting. Bipolar depression. Nice, March 2007.
    Goodwin GM; Anderson I; Arango C; Bowden CL; Henry C; Mitchell PB; Nolen WA; Vieta E; Wittchen HU
    Eur Neuropsychopharmacol; 2008 Jul; 18(7):535-49. PubMed ID: 18501566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Towards precision medicine for pain: diagnostic biomarkers and repurposed drugs.
    Niculescu AB; Le-Niculescu H; Levey DF; Roseberry K; Soe KC; Rogers J; Khan F; Jones T; Judd S; McCormick MA; Wessel AR; Williams A; Kurian SM; White FA
    Mol Psychiatry; 2019 Apr; 24(4):501-522. PubMed ID: 30755720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Right care, first time: a highly personalised and measurement-based care model to manage youth mental health.
    Hickie IB; Scott EM; Cross SP; Iorfino F; Davenport TA; Guastella AJ; Naismith SL; Carpenter JS; Rohleder C; Crouse JJ; Hermens DF; Koethe D; Markus Leweke F; Tickell AM; Sawrikar V; Scott J
    Med J Aust; 2019 Nov; 211 Suppl 9():S3-S46. PubMed ID: 31679171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying blood biomarkers for mood disorders using convergent functional genomics.
    Le-Niculescu H; Kurian SM; Yehyawi N; Dike C; Patel SD; Edenberg HJ; Tsuang MT; Salomon DR; Nurnberger JI; Niculescu AB
    Mol Psychiatry; 2009 Feb; 14(2):156-74. PubMed ID: 18301394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic risk prediction and neurobiological understanding of alcoholism.
    Levey DF; Le-Niculescu H; Frank J; Ayalew M; Jain N; Kirlin B; Learman R; Winiger E; Rodd Z; Shekhar A; Schork N; Kiefer F; Wodarz N; Müller-Myhsok B; Dahmen N; ; Nöthen M; Sherva R; Farrer L; Smith AH; Kranzler HR; Rietschel M; Gelernter J; Niculescu AB
    Transl Psychiatry; 2014 May; 4(5):e391. PubMed ID: 24844177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Pharmacogenomics of Bipolar Disorder study (PGBD): identification of genes for lithium response in a prospective sample.
    Oedegaard KJ; Alda M; Anand A; Andreassen OA; Balaraman Y; Berrettini WH; Bhattacharjee A; Brennand KJ; Burdick KE; Calabrese JR; Calkin CV; Claasen A; Coryell WH; Craig D; DeModena A; Frye M; Gage FH; Gao K; Garnham J; Gershon E; Jakobsen P; Leckband SG; McCarthy MJ; McInnis MG; Maihofer AX; Mertens J; Morken G; Nievergelt CM; Nurnberger J; Pham S; Schoeyen H; Shekhtman T; Shilling PD; Szelinger S; Tarwater B; Yao J; Zandi PP; Kelsoe JR
    BMC Psychiatry; 2016 May; 16():129. PubMed ID: 27150464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Bipolar Prodrome Symptom Interview and Scale-Prospective (BPSS-P): description and validation in a psychiatric sample and healthy controls.
    Correll CU; Olvet DM; Auther AM; Hauser M; Kishimoto T; Carrión RE; Snyder S; Cornblatt BA
    Bipolar Disord; 2014 Aug; 16(5):505-22. PubMed ID: 24807784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.